PDGF-BB protects cardiomyocytes from apoptosis and improves contractile function of engineered heart tissue

Journal of Molecular and Cellular Cardiology

Volumn 48, Issue 6, 2010, Pages 1316-1323

  Vantler, Marius ^a   Karikkineth, Bijoy Chandapillai ^b   Naito, Hiroshi ^b   Tiburcy, Malte ^b,c   Didié, Michael ^b,c   Nose, Monika ^b   Rosenkranz, Stephan ^a   Zimmermann, Wolfram H ^b,c  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Apoptosis; Contractility; Hypertrophy; PDGF; Tissue engineering

Indexed keywords

ACTIN; ATRIAL NATRIURETIC FACTOR; CALSEQUESTRIN; CASPASE 3; MYOSIN HEAVY CHAIN ALPHA; MYOSIN HEAVY CHAIN BETA; PHENYLALANINE; PLATELET DERIVED GROWTH FACTOR BB; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN KINASE B; THYMIDINE;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL ISOLATION; CELL PROLIFERATION; CELL PROTECTION; CELL STIMULATION; CELL STRUCTURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; MONOLAYER CULTURE; MUSCLE ISOMETRIC CONTRACTION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE ENGINEERING;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; CELL PROLIFERATION; CHROMONES; ENZYME INHIBITORS; HEART; MORPHOLINES; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; PHENYLALANINE; PLATELET-DERIVED GROWTH FACTOR; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TISSUE ENGINEERING;

RATTUS;

EID: 77952675467     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.03.008     Document Type: Article

References (22)

1. Harrington E.A., Bennett M.R., Fanidi A., Evan G.I. c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J 1994, 13:3286-3295.
2. Romashkova J.A., Makarov S.S. NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature 1999, 401:86-90.
3. Vantler M., Caglayan E., Zimmermann W.H., Baumer A.T., Rosenkranz S. Systematic evaluation of anti-apoptotic growth factor signaling in vascular smooth muscle cells. Only phosphatidylinositol 3′-kinase is important. J Biol Chem 2005, 280:14168-14176.
4. Vantler M., Huntgeburth M., Caglayan E., Ten Freyhaus H., Schnabel P., Rosenkranz S. PI3-kinase/Akt-dependent antiapoptotic signaling by the PDGF alpha receptor is negatively regulated by Src family kinases. FEBS Lett 2006, 580:6769-6776.
5. Rosenkranz S., Kazlauskas A. Evidence for distinct signaling properties and biological responses induced by the PDGF receptor alpha and beta subtypes. Growth Factors 1999, 16:201-216.
6. Sachinidis A., Gissel C., Nierhoff D., Hippler-Altenburg R., Sauer H., Wartenberg M., Hescheler J. Identification of plateled-derived growth factor-BB as cardiogenesis-inducing factor in mouse embryonic stem cells under serum-free conditions. Cell Physiol Biochem 2003, 13:423-429.
7. Hsieh P.C., Davis M.E., Gannon J., MacGillivray C., Lee R.T. Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers. J Clin Invest 2006, 116:237-248.
8. Bishopric N.H., Simpson P.C., Ordahl C.P. Induction of the skeletal alpha-actin gene in alpha 1-adrenoceptor-mediated hypertrophy of rat cardiac myocytes. J Clin Invest 1987, 80:1194-1199.
9. Naito H., Melnychenko I., Didie M., Schneiderbanger K., Schubert P., Rosenkranz S., Eschenhagen T., Zimmermann W.H. Optimizing engineered heart tissue for therapeutic applications as surrogate heart muscle. Circulation 2006, 114:I72-I78.
10. Zimmermann W.H., Schneiderbanger K., Schubert P., Didie M., Munzel F., Heubach J.F., Kostin S., Neuhuber W.L., Eschenhagen T. Tissue engineering of a differentiated cardiac muscle construct. Circ Res 2002, 90:223-230.
11. Communal C., Sumandea M., de Tombe P., Narula J., Solaro R.J., Hajjar R.J. Functional consequences of caspase activation in cardiac myocytes. Proc Natl Acad Sci U S A 2002, 99:6252-6256.
12. Zimmermann W.H., Fink C., Kralisch D., Remmers U., Weil J., Eschenhagen T. Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. Biotechnol Bioeng 2000, 68:106-114.
13. Zimmermann W.H., Didie M., Doker S., Melnychenko I., Naito H., Rogge C., Tiburcy M., Eschenhagen T. Heart muscle engineering: an update on cardiac muscle replacement therapy. Cardiovasc Res 2006, 71:419-429.
14. El-Armouche A., Singh J., Naito H., Wittkopper K., Didie M., Laatsch A., Zimmermann W.H., Eschenhagen T. Adenovirus-delivered short hairpin RNA targeting PKCalpha improves contractile function in reconstituted heart tissue. J Mol Cell Cardiol 2007, 43:371-376.
15. Eschenhagen T., Zimmermann W.H., Kleber A.G. Electrical coupling of cardiac myocyte cell sheets to the heart. Circ Res 2006, 98:573-575.
16. Radisic M., Park H., Chen F., Salazar-Lazzaro J.E., Wang Y., Dennis R., Langer R., Freed L.E., Vunjak-Novakovic G. Biomimetic approach to cardiac tissue engineering: oxygen carriers and channeled scaffolds. Tissue Eng 2006, 12:2077-2091.
17. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
18. Kundra V., Escobedo J.A., Kazlauskas A., Kim H.K., Rhee S.G., Williams L.T., Zetter B.R. Regulation of chemotaxis by the platelet-derived growth factor receptor-beta. Nature 1994, 367:474-476.
19. Valius M., Kazlauskas A. Phospholipase C-gamma 1 and phosphatidylinositol 3 kinase are the downstream mediators of the PDGF receptor's mitogenic signal. Cell 1993, 73:321-334.
20. Armstrong M.T., Lee D.Y., Armstrong P.B. Regulation of proliferation of the fetal myocardium. Dev Dyn 2000, 219:226-236.
21. Ponten A., Folestad E.B., Pietras K., Eriksson U. Platelet-derived growth factor D induces cardiac fibrosis and proliferation of vascular smooth muscle cells in heart-specific transgenic mice. Circ Res 2005, 97:1036-1045.
22. Ponten A., Li X., Thoren P., Aase K., Sjoblom T., Ostman A., Eriksson U. Transgenic overexpression of platelet-derived growth factor-C in the mouse heart induces cardiac fibrosis, hypertrophy, and dilated cardiomyopathy. Am J Pathol 2003, 163:673-682.